Effect of American ginseng extract (Panax quinquefolius) on formalin-induced nociception in mice

American Journal of Chinese Medicine

Volumn 29, Issue 1, 2001, Pages 149-154

  Yang, J C ^a   Pang, C S ^a   Tsang, S F ^a   Ng, K F ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; FORMALDEHYDE; PLANT EXTRACT;

ANIMAL; ARTICLE; GINSENG; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; MEDICINAL PLANT; MOUSE; PAIN ASSESSMENT;

ANALGESICS; ANIMALS; FORMALDEHYDE; MALE; MICE; MICE, INBRED ICR; PAIN MEASUREMENT; PANAX; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 0035235302     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X01000162     Document Type: Article

References (16)

1. Attele, A.S., J.A. Wu and C.S. Yuan. Ginseng pharmacology. Multiple constituents and multiple actions. Biochem. Pharmacol. 58: 1685-1693, 1999.
2. Austin, J.A. Why patients use alternative medicine? Results of a national study. JAMA 279: 1548-1553, 1998.
3. Cui, J., M. Garle, P. Eneroth and I. Björkhem. What do commercial ginseng preparation contain? Lancet 344: pp. 134, 1994.
4. Dubuisson, D. and S.G. Dennis. The formalin test: a quantitative study of analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4: 161-174, 1977.
5. Malmberg, A.B. and T.L. Yaksh. Antinociceptive actions of spinal non-steroidal anti-inflammatory agents on the formalin test in the rats. J. Pharm. Exp. Ther. 263: 136-146, 1992.
6. Melzack, R. The tragedy of needless pain. Scientific American 262: (2) 27-33, 1990.
7. Mogil, J.S., Y.H. Shin, E.W. McCleskey, S.C. Kim and S.Y. Nah. Gingenoid Rf, a trace component of ginseng root, produces antinocicpetion in mice. Brain Res. 792: (2) 218-228, 1998.
8. ++ channels through a pertussis toxin-sensitive G protein. Proc. Natl. Acad. Sci. 92: 8739-8743, 1995.
9. Nayak, S., S.C. Shiflett, R. Matheis and P. Aqostinellis. Use of complementary and alternative medicine for chronic pain following spinal cord injury. American Pain Society 1999, pp. 4.
10. Parik, W.H., M.K. Parz, K.J. Choi and Y.H. Cho. Isolation of gensenoids Rb1, RB2, Rc, Rd, Re, Rf and Rg1 from ginseng root by high performance liquid chromatograph. Arch. Pharmacol. Res. 5: 7-12, 1982.
11. Puig, S. and L.S. Sorkin. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain 64: 345-355, 1996.
12. Shan, J.J. Personal communication from CV Technologies, Canada 1999.
13. Tjölsen, A., O.G. Berge, S. Hunskaar, J.H. Rosland, and K. Hole. The formalin test: an evaluation of the method. Pain 51: 5-17, 1992.
14. Vogler, B.K., M.H. Pittler and E. Ernst. The efficacy of ginseng. A systemic review of randomised clinical trials. Eur. J. Clin. Pharmacol. 55: 567-575, 1999.
15. Yamamoto, T. and T.L. Yaksh. Comparison of the antinoceceptive effects of pre- and post-treatment with intrathecal morphine and MK801, and NMDA antagonist on the formalin test in the rat. Anaesthesiology 77: 757-763, 1992.
16. Zimmermann, M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110, 1983.